Home Applications 761336 Application 761336
Type BLA
Sponsor ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761336 Anktiva nogapendekin alfa inbakicept-pmln 351(a) Rx 2026-07-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ANKTIVA nogapendekin alfa inbakicept-pmln SOLUTION;INTRAVESICAL 400mcg/0.4 mL No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ANKTIVA NOGAPENDEKIN ALFA INBAKICEPT-PMLN Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc. eae31db8-3e7a-d9e0-708d-74419d1b50ff 2025-06-24 Warnings, Adverse reactions Exact identifier application number: BLA761336
Documents# Document, Submission type, Date table Document Submission type Date 78539 ORIG 2024-05-22 78211 ORIG 2024-04-23 78202 ORIG 2024-04-22